Veristat
Budget
Not declared
EP Access
0
accredited persons
Staff
8
3.25 FTE
EU Grants
None
Mission & Goals
Veristat LLC is the science-first full-service drug and biologic CRO and consultancy that integrates strategic planning, regulatory expertise, and clinical trial execution to rapidly advance the most complex or novel therapies. Our scientific experts design and conduct the global activities required for any clinical, regulatory, or commercialization program comprehensively and efficiently. Veristat meets clients’ needs through every stage of the product lifecycle. Our team has a proven track record in specific areas of expertise & excellent understanding of products’ lifecycle.
EU Legislative Interests
- EU Pharmaceutical Strategy - European Health Union, HERA - Implementation of Medical Devices Regulation and In-vitro Diagnostics Regulation - Orphan Medicinal Products Regulation, Pediatric Regulation and their revision - Revision of the EU general pharmaceutical legislation - Incentives on medicinal products - Advanced Therapy Medicinal Products Regulation - Planned EU Biotech Act - Planned EU Critical Medicines Act - Europe’s Beating Cancer Plan - Clinical Trials Regulation and Clinical Trials Information System - European Medicines Agency policy on publication of clinical data for medicinal products for human use - Implementation of Regulation on Health Technology Assessment - Cross-border healthcare - EUnetHTA - EU pharmacovigilance system - EU personalized medicine activities such as use of '-omics' technologies in the development of personalized medicine - Access to Medicines - Shortages of medicinal products and medical devices - Horizon Europe - European Data Strategy, Artificial Intelligence and Cybersecurity - Data Governance Act and Data Act - Digital infrastructure and cybersecurity - Regulation on Artificial Intelligence - European Health Data Space - General Data Protection Regulation - European Green Deal - Circular Economy Action Plan - EU strategy for chemicals sustainability - Regulation on the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) - PFAS regulations - Planned Chemicals Industry Package - EU industrial strategy - Planned EU Clean Industrial Deal - EU Competitiveness Compass - Planned Single Market Strategy - Planned EU Innovation Act - Planned EU Research Area Act
Communication Activities
Veristat supports its clients with impact analysis and strategic communication advice on the dossiers and activities listed under ‘Main EU initiatives, policies and legislative files monitored by your organisation’. Veristat advises on internal organizational matters to help clients formulate aligned positions and speak with one voice to regulators, policymakers and other stakeholders.
Interests Represented
Advances interests of their clients
Member Of
SFL is a member of SWISS MEDTECH. SFL is a member of the British-Swiss Chamber of Commerce.
Commissioner Meetings
No recorded meetings with EU commissioners.